U.S. Residential REITs Stock News

Rocky Brands (RCKY) FY 2025 earnings snapshot Rocky Brands (RCKY) closed FY 2025 with fourth quarter revenue of US$139.7 million and basic EPS of US$0.87, supported by trailing twelve month revenue of US$482.0 million and EPS of US$2.98 as the latest earnings release hit the tape. The company has seen quarterly revenue move from US$128.1 million and EPS of US$0.64 in Q4 2024 to US$139.7 million and US$0.87 in Q4 2025. Net profit margin over the last 12 months sits at 4.6% compared with 2.5% a...

Pinterest (NYSE:PINS) is overhauling its sales and go to market approach, with management spotlighting new monetization efforts. The company is bringing in new board members to deepen its commerce and advertising capabilities. Leadership is positioning these changes as a pivot that could reshape how Pinterest turns user engagement into revenue. Pinterest sits at the intersection of visual discovery, shopping intent, and digital advertising. This keeps it closely linked to how brands spend...

Setting the stage after recent trading moves Amneal Pharmaceuticals (AMRX) has drawn fresh attention after recent trading moves, with the stock closing around $14.58 and showing mixed short term returns along with positive performance over the past 3 months and year. See our latest analysis for Amneal Pharmaceuticals. While the 1-day and 7-day share price returns show a small pullback, the 30-day and 90-day share price returns, together with a very large 3-year total shareholder return,...

eToro Group (NasdaqGS:ETOR) released new survey findings on Gen Z and millennial retail investors. The survey shows younger investors are spreading capital across bonds, foreign equities, real estate, cryptocurrencies, and commodities. The results point to broader diversification beyond the meme stock trading that drew attention in earlier years. eToro operates as a multi asset investing platform, giving retail investors access to a wide range of securities and asset classes in a single...

Why Palvella Therapeutics Has Caught Investor Attention Recent trading in Palvella Therapeutics (PVLA) has drawn attention after a sharp share price move, with the stock closing at US$128.60 and posting very large 1 year total returns. That type of performance, together with reported annual revenue growth of 63.12% and net income growth of 54.52% on a net loss of US$32.37 million, is prompting investors to reassess how they view this clinical stage biopharmaceutical name. See our latest...

Veracyte, ticker NasdaqGM:VCYT, plans to present more than 15 abstracts from its urology portfolio at the 2026 ASCO Genitourinary Cancers Symposium. The company is preparing to launch its TrueMRD test for muscle invasive bladder cancer and continues to build out its broader genomic testing offerings. Veracyte enters this news cycle with its shares at $35.72 and a mixed return profile, including a 50.7% gain over three years alongside a 15.7% decline year to date and a 12.0% decline over the...

AXIS Capital Holdings (NYSE:AXS) announced the retirement of board member Thomas Ramey. His retirement represents a change in the company’s board-level governance structure. For you as an investor, board changes at an insurer like AXIS Capital Holdings matter because they sit close to decisions on risk appetite, capital allocation and long term priorities. The company operates in specialty insurance and reinsurance, areas that can be influenced by evolving regulation and changing views on...

If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly. The stock has seen a 21.3% decline over the last 30 days and is down 22.3% over the past year, which may have shifted how the market views its growth potential and risk profile. Recent coverage has focused on Veeva Systems' role as a key software provider to life sciences companies and how its customer relationships...

AMC Entertainment Holdings (AMC) is back in focus after Muvico, a wholly owned subsidiary, launched a US$1.73b first lien notes offering tied to a new US$750m term loan and broader refinancing plans. See our latest analysis for AMC Entertainment Holdings. That refinancing announcement lands after a tough stretch for holders, with the share price at US$1.16 and recent moves including a 22.15% 30 day share price decline and a 64.42% 1 year total shareholder return loss, suggesting momentum has...

WaterBridge Infrastructure (NYSE:WBI) has announced the initiation of its first quarterly dividend, marking a new approach to capital returns. The company has also launched the open season for its Speedway Phase II Pipeline project, inviting commercial commitments for new capacity. Both announcements were released together as part of a broader update on corporate priorities and capital allocation. For investors following NYSE:WBI, these developments relate directly to how the company is...

The Trump administration’s new 15% global tariff, set for up to 150 days, has put fresh attention on Brunswick (BC). The stock fell 7.1% as investors reassessed trade sensitive exposure. See our latest analysis for Brunswick. That tariff driven 1 day share price decline of 3.35%, alongside a 9.26% 7 day and 5.50% 30 day share price pullback, comes after a stronger 21.62% 90 day share price return and 33.04% 1 year total shareholder return. This suggests recent momentum has cooled even as...

Event context and recent stock move Dollar General (DG) has drawn fresh attention after a period of strong share price performance, with the stock showing a return of about 42% over the past 3 months. For investors, that move naturally raises questions about how the current price lines up with the company’s fundamentals, including profitability and overall value profile. See our latest analysis for Dollar General. Looking beyond the recent 3 month share price return, Dollar General’s latest...

On February 19, 2026, Zurn Elkay Water Solutions’ subsidiaries entered into Amendment No. 3 to their first lien credit agreement, refinancing existing revolving borrowings, expanding the revolving credit facility from US$200,000,000 to US$550,000,000, and extending the facility’s maturity to February 19, 2031. The revised agreement, which ties interest margins and fees to net first lien leverage and boosts remaining borrowing capacity to US$540,100,000, materially increases Zurn Elkay’s...

Sprouts Farmers Market appointed Amanda Rassi as its first chief customer officer and Don Clark as chief merchandising officer. The leadership changes signal a fresh focus on customer engagement, personalization and merchandising across the business. Investors are watching how the new C-suite structure will influence shopper loyalty and sales trends. Sprouts Farmers Market (NasdaqGS: SFM) is entering this leadership reset with a share price of $73.73. The stock has seen a 9.0% return over...

Allison Transmission Holdings (ALSN) closed out FY 2025 with Q4 revenue of US$737 million and basic EPS of US$1.19, alongside net income of US$99 million that sets the tone for how investors read the full year. The company has seen quarterly revenue move from US$824 million in Q3 2024 to US$814 million in Q2 2025, US$693 million in Q3 2025 and then US$737 million in Q4 2025. Basic EPS shifted from US$2.30 to US$2.32, US$1.63 and US$1.19 over the same stretch, giving a clear read on how top...

Navitas Semiconductor (NVTS) has just wrapped up FY 2025 with fourth quarter revenue of US$7.3 million and a basic EPS loss of US$0.14, while trailing 12 month figures show revenue of US$45.9 million and a full year EPS loss of US$0.57. Over the past few quarters, the company has seen revenue move from US$21.7 million with EPS of US$0.10 loss in Q3 2024 to US$10.1 million and EPS of US$0.09 loss in Q3 2025, alongside net income losses ranging from US$18.7 million to US$31.8 million in recent...

WisdomTree snapshot WisdomTree (WT) has drawn fresh attention after a stretch of strong returns across multiple timeframes, with the stock showing gains over the past week, month, past 3 months and year to date. That recent performance sits alongside reported annual revenue of US$493.753m and net income of US$109.133m, giving investors a reference point for assessing how the exchange traded fund sponsor and asset manager compares with its share price. See our latest analysis for...

In February 2026, Sensata Technologies Holding plc reported fourth-quarter 2025 sales of US$917.9 million and net income of US$63.2 million, alongside full-year 2025 sales of US$3.70 billion and net income of US$31.3 million. Despite lower full-year revenue and earnings versus the prior year, the company delivered a sharp quarterly profit rebound and reorganized into three segments that each achieved organic revenue growth and margin expansion. Now we will examine how Sensata’s stronger...

What triggered the latest interest in Nucor stock Nucor (NUE) has drawn fresh attention after its Board approved a new US$4.0b share repurchase program, reaffirmed a regular US$0.56 quarterly dividend, and appointed Jack Sullivan as Chief Financial Officer. See our latest analysis for Nucor. Nucor's latest US$4.0b buyback authorization and continued dividend track record come after a mixed stretch for the share price, with a 7 day share price return of 4.91% decline, a 90 day share price...

Teekay Tankers (TNK) is back in focus after its fourth quarter 2025 earnings, where net income and earnings per share were higher year over year, alongside ongoing fleet renewal and a continued quarterly dividend. See our latest analysis for Teekay Tankers. The latest earnings news comes after a strong run for the shares, with a 30 day share price return of 21.68% and a year to date share price return of 45.18%. The 1 year total shareholder return of 96.06%, together with a very large 5 year...

Merit Medical Systems (MMSI) closed FY 2025 with fourth quarter revenue of US$393.9 million and basic EPS of US$0.64, supported by trailing twelve month revenue of US$1.5 billion and EPS of US$2.17 that frame the full year picture. Over the past six reported quarters, the company has seen quarterly revenue move from US$339.8 million in Q3 2024 to US$393.9 million in Q4 2025, while quarterly basic EPS ranged between US$0.47 and US$0.64 across that stretch. With trailing net profit margin at...

Institutional buying and late stage trials draw attention to Kodiak Sciences Baker Bros. Advisors recently expanded its position in Kodiak Sciences (KOD) by 2,608,696 shares, an estimated US$53.42 million purchase that is putting fresh focus on the biotech as its retinal disease programs advance. See our latest analysis for Kodiak Sciences. Kodiak Sciences’ share price has been volatile, with a 12.37% 7 day share price return and 23.08% 90 day share price return. Its 1 year total shareholder...

If you are wondering whether Newell Brands at US$4.56 is a bargain or a value trap, you are not alone. This article is here to unpack what the current share price might be implying. The stock has had mixed returns, with a 3.2% decline over the last 7 days, a 4.6% gain over the last 30 days, a 22.6% gain year to date, and a 24.3% decline over the past year. These moves can change how investors think about both upside potential and risk. Recent company updates and ongoing restructuring efforts...

If you are wondering whether Pulse Biosciences at around US$19.21 is priced fairly or if the market is getting ahead of itself, this article walks through what the numbers indicate about its value. The share price has had a mixed run, with a 24.5% decline over the last week, a 34.1% gain over the last month, a 43.5% gain year to date, a 0.7% decline over the last year, a very large 3 year return of around 7x, and a 30.8% decline over five years. Recent news coverage around Pulse Biosciences...